On Ho, PhD

Articles by On Ho, PhD

Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017

ByNatasza Posielski, MD,Hannah Koenig, MPH,On Ho, PhD,Christopher R. Porter, MD,John Paul Flores, MD

January 20th 2022

Patients 70 years or older that received neoadjuvant chemotherapy and radical cystectomy had better overall survival than those undergoing radical cystectomy alone.

Latest Updated Articles

Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017
January 20th 2022

On Ho, PhD

Articles by On Ho, PhD

Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors

Intismeran Plus Pembrolizumab Reduces Recurrence Risk in Resected Melanoma

ESMO 2026: The Presentations That May Transform The Lung Cancer Paradigm

Sunvozertinib Now Available in US for EGFR Exon 20+ NSCLC

From KEYNOTE-B49 to Novel ADCs: Breast Cancer Trials to Watch at ESMO 2026